KP Tissue Inc (KPT) Fair Value & Analysis
Consumer Defensive · CA · Market cap C$130M
Fair value as of: Aug 13, 2026
From 8 valuation models · updated yesterday
Share price −1.3% over the past month.
A solid business, screening 38% undervalued on our models.
What matters now
- The rarer combination: high quality (71/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (C$13.36). The market is more pessimistic than our downside scenario.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range C$6.73 – C$13.40 · fair‑value band C$13.36 – C$22.26 · the C$12.87 price screens below the C$17.81 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
KP Tissue Inc (KPT) currently trades at C$12.87, while our model-based Fair Value estimate is C$17.81, implying the stock looks roughly 38.4% undervalued today. The Quality Score stands at 71/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
It earns a return on equity of 12.2%. The stock trades on a trailing P/E of 14.3. Fundamentals as of Aug 13, 2026
Our scenario range runs from C$13.36 (bear case) to C$22.26 (bull case); at C$12.87, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 55% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at 38%, KPT screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 8 models by family
Widest divergence: Multiples (C$14.42) versus Asset-Based (C$4.66). Highest evidence: Residual Income (76).
Notify me when KPT reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 68 · Market factors (momentum, volatility) 84
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins.
Full company description
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterra and White Cloud. brand names, as well as under private labels. It sells its products through the retail channels, such as grocery stores, mass merchandisers, club stores, drug stores, and convenience stores; and distributors to businesses involved in property management, health care, food service, manufacturing and lodging, education, and lodging. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
KP Tissue Inc reported revenue of C$0 in FY2025 versus C$0 in FY2021. Reported net income was C$8.5M in FY2025, compounding +61.9%/yr from FY2021.
Watch KPT: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 252 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 30/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $144.26 | $108.16 | -25% |
| Unilever PLC ULN | 1,080 MXN | 973.58 MXN | -10% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,063 | ₹789.46 | -62% |
| Essity AB ESSITYA | kr 276.50 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹936.90 | ₹367.64 | -61% |
| Marico Limited MARICO | ₹855.00 | ₹233.05 | -73% |
| APR Co 278470 | 397,000 KRW | 137,521 KRW | -65% |
| Dabur India Limited DABUR | ₹411.25 | ₹175.59 | -57% |
| PT Unilever Indonesia Tbk UNVR | 1,760 IDR | 1,928 IDR | +10% |
| Amorepacific Corporation 090430 | 135,700 KRW | 84,785 KRW | -38% |
Compare KP Tissue Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is KP Tissue Inc (KPT) overvalued or undervalued?
What is the fair value of KPT?
What is the quality score of KPT?
What is the net profit margin of KPT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track KP Tissue Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.